Chemoinformaics analysis of L-Ascorbic Acid
| Molecular Weight | 176.124 | nRot | 2 |
| Heavy Atom Molecular Weight | 168.06 | nRig | 5 |
| Exact Molecular Weight | 176.032 | nRing | 1 |
| Solubility: LogS | -0.613 | nHRing | 1 |
| Solubility: LogP | -1.42 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 20.1663 |
| nHD | 4 | BPOL | 10.6297 |
| QED | 0.412 |
| Synth | 4.044 |
| Natural Product Likeliness | 1.746 |
| NR-PPAR-gamma | 0.247 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.089 |
| HIA | 0.069 |
| CACO-2 | -5.917 |
| MDCK | 0.000142819 |
| BBB | 0.073 |
| PPB | 0.632297 |
| VDSS | 0.937 |
| FU | 0.365764 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.052 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.23 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.157 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.028 |
| CL | 9.964 |
| T12 | 0.928 |
| hERG | 0.015 |
| Ames | 0.027 |
| ROA | 0.06 |
| SkinSen | 0.837 |
| Carcinogencity | 0.266 |
| EI | 0.169 |
| Respiratory | 0.096 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.886938 |